Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could be adapted to fight many kinds of cancer. Early experiments in animals and ...

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...

Peptides are short chains of amino acids. They arrive as powders labelled “for research use only,” are mixed at home with ...

With President Donald Trump back in the White House in 2025, it’s no surprise that he dominates the FactCheck.org year-end ...

Here are five medical breakthroughs that gave us hope in 2025. In February, a baby with a rare, often fatal genetic disorder ...

For immunocompromised patients who've never had a COVID shot or only had an incomplete series, guidelines from the Advisory ...

A new study finds that at least one Archaea has surprisingly flexibility when interpreting genetic code, which goes against a ...

The study suggests the tests could save lives by catching cancer at earlier stages, when it's more easily treated. It predicted that, over a decade of use, MCEDs could reduce stage IV cancer diagnoses ...

Explore how engineered extracellular vesicles can enhance antigen-specific regulatory T cells to improve immune response.

From GLP-1 weight-loss drugs and mRNA cancer vaccines to longevity science and regenerative medicine, 2025 marked a decisive ...

A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...